Efficacy of tyrosine kinase inhibitors in Ph-like acute lymphoblastic leukemia harboring ABL-class rearrangementsIlaria Tanasi, Emmanuelle Clappier, Jérôme Tamburini et al.|Blood|2019Cited by 136